Literature DB >> 954012

Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.

C G Moertel, A J Schutt, R J Reitemeier, R G Hahn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954012

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

Review 1.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

2.  Palliative and adjunctive measures in rectal cancer.

Authors:  A Fritsch; W Seidl; C Walzel; K Moser; R Schiessel
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

3.  13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial.

Authors:  C F Slabber; G Falkson; W Burger; L Schoeman
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

4.  Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.

Authors:  R A Kramer; M G McMenamin; M R Boyd
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Studies in an animal model on the effectiveness of adjuvant chemotherapy with 5-FU and BCNU in cases of colorectal adenocarcinoma.

Authors:  R Schmitz; J Hüper; R Pichlmayr
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.

Authors:  S Bhide; M Habs; H Reinbold; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1979-05-14       Impact factor: 4.553

7.  Trimetrexate in advanced carcinoma of the esophagus.

Authors:  A S Alberts; G Falkson; M Badata; A P Terblanche; E U Schmid
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.